revenues totaled $num-one billion, and our adjusted earnings per share was $num-two, both ahead of our expectations.
our adjusted earnings per share increased num-one% over the prior year to $num-two on a reported basis and were up num-three% on a currency-neutral basis.
however, we did start to see some impact on elective procedures from the covid delta variant in the last one to two weeks in certain u.s. states and have assumed some continuation of this in our guidance.